ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,240Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 738

$2.27M Total Retail Price of All Prescriptions

Rank: 4 out of 738

808 Patients Receiving at Least One Drug in Part D
58%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 808 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

1% of this provider’s 808 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

5% of this provider’s 5,458 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$172 was the average price of a prescription from this provider, compared to $113 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
RISPERIDONE 1,044 506 1 2
MIRTAZAPINE 754 405 2 10
BENZTROPINE MESYLATE 693 218 R 3 6
TRAZODONE HCL 619 327 4 1
QUETIAPINE FUMARATE 607 260 5 9
CITALOPRAM HBR 571 414 6 4
DIVALPROEX SODIUM 411 275 7 23
HALOPERIDOL 405 81 8 29
OLANZAPINE 392 128 9 18
INVEGA SUSTENNA 367 41 10 55
FLUOXETINE HCL 337 121 11 8
ABILIFY 308 43 12 7
SERTRALINE HCL 279 163 13 5
RISPERDAL CONSTA 278 102 14 51
CYMBALTA 264 112 15 11
BUPROPION XL 263 91 16 15
SEROQUEL 262 105 17 27
DONEPEZIL HCL 239 190 18 21
ESCITALOPRAM OXALATE 238 143 19 14
DIVALPROEX SODIUM ER 238 34 19 24
SEROQUEL XR 210 105 21 13
PAROXETINE HCL 189 86 22 16
HALOPERIDOL DECANOATE 178 29 23 48
ZOLPIDEM TARTRATE 178 99 23 3
VENLAFAXINE HCL ER 176 84 25 19
LAMOTRIGINE 169 35 26 12
TRIHEXYPHENIDYL HCL 137 37 R 27 46
NAMENDA 137 102 27 26
CLOZAPINE 127 31 29 31
FLUPHENAZINE HCL 108 16 30 43
GABAPENTIN 105 36 31 33
BUPROPION HCL SR 101 63 32 22
OLANZAPINE ODT 101 31 32 100
TOPIRAMATE 95 25 34 39
ZIPRASIDONE HCL 94 0 35 36
VENLAFAXINE HCL 83 36 36 40
LITHIUM CARBONATE 79 12 37 25
HYDROXYZINE PAMOATE 79 0 R 37 32
BUSPIRONE HCL 77 31 39 20
INVEGA 75 0 40 61
ZYPREXA 73 21 41 82
AMPHETAMINE SALT COMBO 73 20 S2 41 37
LEVOTHYROXINE SODIUM 64 30 43 62
LEXAPRO 53 30 44 35
ALPRAZOLAM 53 48 44 17
TRIFLUOPERAZINE HCL 53 0 44 57
ARICEPT 52 35 47 123
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 24, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.